1-6 of 6
Zhen Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts

Free
Ping Jin, Xin Li, Yu Xia, Huayi Li, Xiaoting Li, Zong-Yuan Yang, Zhen Wang, Cheng Xu, Tian Fang, Dongchen Zhou, Xiaoming Xiong, Si-Yuan Wang, Sen Xu, Qinglei Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (4): 447–458.
https://doi.org/10.1158/1535-7163.MCT-22-0396
Published: 03 April 2023
View article titled, Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
Open the PDF for Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts in another window
Includes: Supplementary data
Journal Articles

Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma

Free
Kristina Y. Aguilera, Huocong Huang, Wenting Du, Moriah M. Hagopian, Zhen Wang, Stefan Hinz, Tae Hyun Hwang, Huamin Wang, Jason B. Fleming, Diego H. Castrillon, Xiaomei Ren, Ke Ding, Rolf A. Brekken
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (11): 2473–2485.
https://doi.org/10.1158/1535-7163.MCT-16-0834
Published: 01 November 2017
View article titled, Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma
Open the PDF for Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

Free
Lai-Ping Zhong, Dong-Wang Zhu, William N. William, Jr, Ying Liu, Jie Ma, Cheng-Zhe Yang, Xiao Yang, Li-Zhen Wang, Jiang Li, Jeffrey N. Myers, J. Jack Lee, Chen-Ping Zhang, Zhi-Yuan Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 1112–1121.
https://doi.org/10.1158/1535-7163.MCT-12-1013
Published: 09 June 2013
View article titled, Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
Open the PDF for Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease in another window
Includes: Supplementary data
Journal Articles

Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo

Free
Xu-Dong Tang, Guo-Zhen Wang, Jun Guo, Mu-Han Lü, Chuan Li, Ning Li, Ya-Ling Chao, Chang-Zhu Li, Yu-Yun Wu, Chang-Jiang Hu, Dian-Chun Fang, Shi-Ming Yang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (5): 1183–1192.
https://doi.org/10.1158/1535-7163.MCT-11-0607
Published: 08 May 2012
View article titled, Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo
Open the PDF for Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo in another window
Journal Articles

Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity

Free
Huw D. Thomas, Kappusamy Saravanan, Lan-Zhen Wang, Mei-Ju Lin, Julian S. Northen, Hannah Barlow, Marion Barton, David R. Newell, Roger J. Griffin, Bernard T. Golding, Nicola J. Curtin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (7): 1828–1837.
https://doi.org/10.1158/1535-7163.MCT-08-1208
Published: 14 July 2009
View article titled, Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity
Open the PDF for Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity in another window
Includes: Supplementary data
Journal Articles

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Free
Huw D. Thomas, Christopher R. Calabrese, Michael A. Batey, Stacie Canan, Zdenek Hostomsky, Suzanne Kyle, Karen A. Maegley, David R. Newell, Donald Skalitzky, Lan-Zhen Wang, Stephen E. Webber, Nicola J. Curtin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (3): 945–956.
https://doi.org/10.1158/1535-7163.MCT-06-0552
Published: 15 March 2007
View article titled, Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Open the PDF for Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial in another window
Includes: Supplementary data